You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 16, 2025

Drug Price Trends for NDC 65162-0893


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for 65162-0893

Drug NameNDCPrice/Unit ($)UnitDate
ARIPIPRAZOLE 1 MG/ML SOLUTION 65162-0893-74 0.57725 ML 2025-03-19
ARIPIPRAZOLE 1 MG/ML SOLUTION 65162-0893-74 0.55877 ML 2025-02-19
ARIPIPRAZOLE 1 MG/ML SOLUTION 65162-0893-74 0.53189 ML 2025-01-22
ARIPIPRAZOLE 1 MG/ML SOLUTION 65162-0893-74 0.48805 ML 2024-12-18
ARIPIPRAZOLE 1 MG/ML SOLUTION 65162-0893-74 0.46003 ML 2024-11-20
ARIPIPRAZOLE 1 MG/ML SOLUTION 65162-0893-74 0.56313 ML 2024-10-23
ARIPIPRAZOLE 1 MG/ML SOLUTION 65162-0893-74 0.67116 ML 2024-09-18
>Drug Name>NDC>Price/Unit ($)>Unit>Date
Showing 1 to 7 of 7 entries

Best Wholesale Price for NDC 65162-0893

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug NameVendorNDCCountPrice ($)Price/Unit ($)DatesPrice Type
ARIPIPRAZOLE 1MG/ML SOLN,ORAL AvKare, LLC 65162-0893-74 150ML 238.69 1.59127 2023-06-15 - 2028-06-14 FSS
>Drug Name>Vendor>NDC>Count>Price ($)>Price/Unit ($)>Dates>Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Showing 1 to 1 of 1 entries

Market Analysis and Price Projections for NDC: 65162-0893 (Aripiprazole by Amneal Pharmaceuticals LLC)

Overview of Aripiprazole

Aripiprazole, marketed under the trade name Abilify among others, is an antipsychotic medication used primarily to treat schizophrenia, bipolar disorder, and major depressive disorder. The NDC code 65162-0893 corresponds to Aripiprazole manufactured by Amneal Pharmaceuticals LLC.

Market Context

Pharmaceutical Market Trends

The pharmaceutical market, particularly the segment involving antipsychotic medications, is subject to various trends and regulatory changes. The biopharma and biotech industries are experiencing rapid growth, driven by technological advancements, evolving regulatory frameworks, and a shift towards patient-centered care[3].

Price Dynamics

Recent Price Changes

Drug prices, including those for generic and branded medications like Aripiprazole, have been increasing over the years. From January 2022 to January 2023, more than 4,200 drug products saw price increases, with 46% of these increases exceeding the rate of inflation. The average price increase during this period was 15.2%, translating to $590 per drug product[2].

Generic vs. Branded Drugs

For multi-source drugs, such as generic versions of Aripiprazole, the percentage price increases tend to be higher compared to single-source drugs. However, the absolute dollar increases are typically larger for single-source (branded) drugs. In the period from January 2022 to January 2023, the average price increase for multi-source drugs was 26.0%, while for single-source drugs it was 7.4%[2].

Specific Price Projections for Aripiprazole

Historical Pricing

While specific historical price data for NDC 65162-0893 is not provided, it is important to note that generic drugs like Aripiprazole generally experience price stability or moderate increases compared to their branded counterparts.

Future Projections

Given the trends in the pharmaceutical industry, here are some key points to consider for future price projections:

  • Generic Competition: As more generic versions of Aripiprazole enter the market, competition is likely to keep prices relatively stable or lead to modest decreases.
  • Regulatory Environment: Changes in regulatory policies, such as those related to drug pricing transparency and affordability initiatives, could impact future price dynamics.
  • Market Demand: The demand for antipsychotic medications, driven by the prevalence of mental health disorders, will continue to influence pricing.

Market Analysis

Market Size and Growth

The global antipsychotic drugs market is expected to grow due to increasing prevalence of mental health disorders and advancements in treatment options. While specific growth projections for Aripiprazole are not detailed, the overall market for antipsychotics is anticipated to expand.

Competitive Landscape

Aripiprazole faces competition from other antipsychotic medications, both branded and generic. The competitive landscape is dynamic, with new drugs and formulations entering the market, which can affect pricing and market share.

Key Takeaways

  • Price Stability: Generic versions of Aripiprazole, such as those manufactured by Amneal Pharmaceuticals LLC, are likely to experience stable or moderately increasing prices.
  • Regulatory Impact: Future price changes will be influenced by regulatory policies and market competition.
  • Market Growth: The antipsychotic drugs market is expected to grow, driven by increasing demand and advancements in treatment options.

FAQs

1. What is the current market trend for antipsychotic medications like Aripiprazole? The market for antipsychotic medications is growing due to increasing prevalence of mental health disorders and advancements in treatment options.

2. How do generic versions of Aripiprazole impact pricing? Generic versions typically lead to stable or moderately decreasing prices due to increased competition.

3. What regulatory factors could influence the price of Aripiprazole? Regulatory policies related to drug pricing transparency, affordability initiatives, and changes in FDA approvals can impact future price dynamics.

4. How does the competitive landscape affect the pricing of Aripiprazole? The presence of other antipsychotic medications, both branded and generic, influences pricing and market share.

5. What are the projected growth rates for the antipsychotic drugs market? The global antipsychotic drugs market is expected to grow, though specific growth rates for Aripiprazole are not detailed in available sources.

Sources

  1. FindACode: NDC Labeler, Manufacturer of Drugs and Pharmaceuticals.
  2. ASPE: Changes in the List Prices of Prescription Drugs, 2017-2023.
  3. TFS CRO: 5 Predictions for the Biopharma and Biotech Industries in 2025.
  4. Drug Development: NSCLC Market - Global Drug Forecast & Market Analysis to 2025.
  5. FDA: National Drug Code Database Background Information.

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.